PL2049153T3 - Atenuowane wirusy polio - Google Patents

Atenuowane wirusy polio

Info

Publication number
PL2049153T3
PL2049153T3 PL07789191T PL07789191T PL2049153T3 PL 2049153 T3 PL2049153 T3 PL 2049153T3 PL 07789191 T PL07789191 T PL 07789191T PL 07789191 T PL07789191 T PL 07789191T PL 2049153 T3 PL2049153 T3 PL 2049153T3
Authority
PL
Poland
Prior art keywords
polio viruses
attenuated polio
attenuated
viruses
polio
Prior art date
Application number
PL07789191T
Other languages
English (en)
Inventor
Andrew Macadam
Original Assignee
Health Prot Agency
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Health Prot Agency filed Critical Health Prot Agency
Publication of PL2049153T3 publication Critical patent/PL2049153T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/13—Poliovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32661—Methods of inactivation or attenuation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PL07789191T 2006-08-10 2007-08-10 Atenuowane wirusy polio PL2049153T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0615933.9A GB0615933D0 (en) 2006-08-10 2006-08-10 Attenuated polioviruses
PCT/GB2007/003065 WO2008017870A1 (en) 2006-08-10 2007-08-10 Attenuated polio viruses
EP07789191A EP2049153B1 (en) 2006-08-10 2007-08-10 Attenuated polio viruses

Publications (1)

Publication Number Publication Date
PL2049153T3 true PL2049153T3 (pl) 2013-08-30

Family

ID=37056165

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07789191T PL2049153T3 (pl) 2006-08-10 2007-08-10 Atenuowane wirusy polio

Country Status (15)

Country Link
US (2) US8557252B2 (pl)
EP (1) EP2049153B1 (pl)
JP (1) JP5222847B2 (pl)
CN (1) CN101522216B (pl)
AU (1) AU2007283199B2 (pl)
CA (1) CA2660375C (pl)
CY (1) CY1113786T1 (pl)
DK (1) DK2049153T3 (pl)
ES (1) ES2401104T3 (pl)
GB (1) GB0615933D0 (pl)
PL (1) PL2049153T3 (pl)
PT (1) PT2049153E (pl)
SI (1) SI2049153T1 (pl)
WO (1) WO2008017870A1 (pl)
ZA (1) ZA200900986B (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201022077D0 (en) 2010-12-29 2011-02-02 Health Prot Agency Inactivated poliovaccine
BR112013030390A2 (pt) * 2012-03-07 2016-09-06 Indian Council Medical Res ensaio para a detecção de substituições de nucleotídeos em genomas de virus de vacina oral sabin de poliovirus
EP3157556B1 (en) * 2014-06-17 2019-10-23 Janssen Vaccines & Prevention B.V. Cold-adapted-viral-attenuation (cava) and novel attenuated poliovirus strains
US20210128713A1 (en) * 2018-03-30 2021-05-06 Biological Mimetics, Inc. Irradiation-inactivated poliovirus, compositions including the same, and methods of preparation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8901094D0 (en) 1989-01-18 1989-03-15 Almond Jeffrey W Attenuated viruses
GB9705669D0 (en) * 1997-03-19 1997-05-07 British Tech Group Attenuated polioviruses
GB9817082D0 (en) 1998-08-06 1998-10-07 Btg Int Ltd Attenuated poliovirus vaccine
GB201022077D0 (en) 2010-12-29 2011-02-02 Health Prot Agency Inactivated poliovaccine

Also Published As

Publication number Publication date
GB0615933D0 (en) 2006-09-20
US20100158945A1 (en) 2010-06-24
JP5222847B2 (ja) 2013-06-26
DK2049153T3 (da) 2013-03-18
ES2401104T3 (es) 2013-04-17
EP2049153B1 (en) 2012-12-12
WO2008017870A1 (en) 2008-02-14
CY1113786T1 (el) 2016-07-27
JP2010500017A (ja) 2010-01-07
US9408903B2 (en) 2016-08-09
CA2660375C (en) 2015-02-03
WO2008017870A8 (en) 2009-07-16
SI2049153T1 (sl) 2013-04-30
EP2049153A1 (en) 2009-04-22
CN101522216A (zh) 2009-09-02
ZA200900986B (en) 2011-04-28
CN101522216B (zh) 2013-03-27
CA2660375A1 (en) 2008-02-14
AU2007283199B2 (en) 2012-11-15
PT2049153E (pt) 2013-03-18
US8557252B2 (en) 2013-10-15
US20140112952A1 (en) 2014-04-24
AU2007283199A1 (en) 2008-02-14

Similar Documents

Publication Publication Date Title
HRP20181319T1 (hr) Oslabljeni virusi koji su korisni kao cjepiva
AP2907A (en) Viral hepatitis treatment
PL3192874T3 (pl) Oczyszczanie wirusa
GB0610096D0 (en) Anti viral spreader
AP2880A (en) Novel viral factor
GB0807424D0 (en) Virus
GB0714578D0 (en) Viruses
HK1131595A1 (en) Stroller
GB0706085D0 (en) Briefs
GB0702946D0 (en) Stoves
ZA200900986B (en) Attenuated polio viruses
PL2019685T3 (pl) Defektywny interferujący wirus
GB2437799B (en) Defective interfering virus
GB0720624D0 (en) Viral Modification
PL1821036T3 (pl) Palnik
GB2440548B (en) Condensate Traps
GB2434860B (en) Cooker
GB0823560D0 (en) Virus
HU3381U (en) Burner owen for pcb-s
GB0617694D0 (en) Viral inactivation
GB0703066D0 (en) Viruses
FI2139515T4 (fi) Taudinaiheuttamiskyvyltään heikennettyjä viruksia, jotka ovat käyttökelpoisia rokotteissa
GB0622190D0 (en) Oncolytic viruses
GB0619445D0 (en) Defective interfering virus
GB0813823D0 (en) Virus